Bio Green Net Income Over Time
| BGMS Stock | 1.01 0.03 3.06% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bio Green Performance and Bio Green Correlation. Is there potential for Health Care Providers & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Green. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Green listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Bio Green Med's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Green's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Bio Green's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Green's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Green should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Green's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Bio Green Med and related stocks such as Bone Biologics Corp, Bullfrog AI Holdings, and MSP Recovery Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBLG | (13.3 K) | (715) | (715) | (1.1 M) | (4.4 M) | (13.9 M) | (25.9 M) | (7.1 M) | (4.4 M) | (3.4 M) | (1.8 M) | (1.6 M) | (1.5 M) | (8.9 M) | (4.1 M) | (3.7 M) | (3.9 M) |
| BFRG | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (585.8 K) | (2.8 M) | (5.4 M) | (7 M) | (6.3 M) | (6 M) |
| MSPR | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (33.1 M) | (7.4 M) | (56.3 M) | (360.5 M) | (324.4 M) | (308.2 M) |
| BNBX | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (8.3 M) | (9.9 M) | (7 M) | (15.2 M) | (13.6 M) | (14.3 M) |
| CNSP | (526.5 K) | (526.5 K) | (526.5 K) | (526.5 K) | (526.5 K) | (526.5 K) | (526.5 K) | (526.5 K) | (7.4 M) | (3.9 M) | (9.5 M) | (14.5 M) | (15.3 M) | (18.9 M) | (14.9 M) | (13.4 M) | (14 M) |
| VERO | (23 M) | (23 M) | (23 M) | (23 M) | (23 M) | (23 M) | (21.8 M) | (17.8 M) | (28.7 M) | (42.3 M) | (82.8 M) | (22.1 M) | (43.7 M) | (37.2 M) | (47 M) | (42.3 M) | (44.4 M) |
| MOVE | 545 K | 7.3 M | 5.6 M | 574 K | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (8.4 M) | (14 M) | (22.6 M) | (30.2 M) | (29.3 M) | (23.7 M) | (21.4 M) | (20.3 M) |
| SXTP | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (3 M) | (4.3 M) | (6.2 M) | (3.8 M) | (7.9 M) | (7.2 M) | (7.5 M) |
Bio Green Med and related stocks such as Bone Biologics Corp, Bullfrog AI Holdings, and MSP Recovery Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Bio Green Med financial statement analysis. It represents the amount of money remaining after all of Bio Green Med operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Bio Green Med | BGMS |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Level 10, Kuala |
| Exchange | NASDAQ Exchange |
null 1.01
Additional Tools for Bio Stock Analysis
When running Bio Green's price analysis, check to measure Bio Green's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Green is operating at the current time. Most of Bio Green's value examination focuses on studying past and present price action to predict the probability of Bio Green's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Green's price. Additionally, you may evaluate how the addition of Bio Green to your portfolios can decrease your overall portfolio volatility.